Genomic analysis of microRNA time-course expression in liver of mice treated with genotoxic carcinogen N-ethyl-N-nitrosourea

BMC Genomics

Volumn 11, Issue 1, 2010, Pages

  Li, Zhiguang ^a   Branham, William S ^a   Dial, Stacey L ^a   Wang, Yexun ^b   Guo, Lei ^a   Shi, Leming ^a   Chen, Tao ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b SABiosciences Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; DNA; ETHYLNITROSOUREA; MICRORNA; MUTAGENIC AGENT; TAQ POLYMERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; COMPUTER MODEL; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME ANALYSIS; LIVER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRINCIPAL COMPONENT ANALYSIS; RNA ISOLATION; ANIMAL; CLUSTER ANALYSIS; DRUG EFFECT; GENETICS; GENOME; GENOMICS; METABOLISM; METHODOLOGY; REPRODUCIBILITY; TIME;

MUS;

ANIMALS; CARCINOGENS; CLUSTER ANALYSIS; ETHYLNITROSOUREA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME; GENOMICS; LIVER; MICE; MICRORNAS; MUTAGENS; POLYMERASE CHAIN REACTION; PRINCIPAL COMPONENT ANALYSIS; REPRODUCIBILITY OF RESULTS; TAQ POLYMERASE; TIME FACTORS;

EID: 77958557351     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-11-609     Document Type: Article

References (64)

1. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 2003, 113(6):673-676. 10.1016/S0092-8674(03)00428-8, 12809598.
2. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
3. Shivdasani RA. MicroRNAs: regulators of gene expression and cell differentiation. Blood 2006, 108(12):3646-3653. 10.1182/blood-2006-01-030015, 1895474, 16882713.
4. Fabbri M, Ivan M, Cimmino A, Negrini M, Calin GA. Regulatory mechanisms of microRNAs involvement in cancer. Expert Opin Biol Ther 2007, 7(7):1009-1019. 10.1517/14712598.7.7.1009, 17665990.
5. Cummins JM, Velculescu VE. Implications of micro-RNA profiling for cancer diagnosis. Oncogene 2006, 25(46):6220-6227. 10.1038/sj.onc.1209914, 17028602.
6. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005, 353(17):1793-1801. 10.1056/NEJMoa050995, 16251535.
7. Hagan JP, Croce CM. MicroRNAs in carcinogenesis. Cytogenet Genome Res 2007, 118(2-4):252-259. 10.1159/000108308, 18000378.
8. Chen T. The role of MicroRNA in Chemical Carcinogenesis. Journal of Environmental Science and Health Part C-Environmental Carcinogenesis & Ecotoxicology Reviews 2010, 28:89-124.
9. Kalscheuer S, Zhang X, Zeng Y, Upadhyaya P. Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 2008, 29(12):2394-2399. 10.1093/carcin/bgn209, 2722864, 18780894.
10. Yu T, Wang XY, Gong RG, Li A, Yang S, Cao YT, Wen YM, Wang CM, Yi XZ. The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. J Exp Clin Cancer Res 2009, 28:64. 10.1186/1756-9966-28-64, 2687417, 19435529.
11. Pogribny IP, Muskhelishvili L, Tryndyak VP, Beland FA. The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation. Toxicol Appl Pharmacol 2009, 235(3):305-311. 10.1016/j.taap.2008.12.021, 19167416.
12. Ilnytskyy Y, Zemp FJ, Koturbash I, Kovalchuk O. Altered microRNA expression patterns in irradiated hematopoietic tissues suggest a sex-specific protective mechanism. Biochem Biophys Res Commun 2008, 377(1):41-45. 10.1016/j.bbrc.2008.09.080, 18823940.
13. Wang J, Liu X, Heflich RH, Chen T. Time course of cII gene mutant manifestation in the liver, spleen, and bone marrow of N-ethyl-N-nitrosourea-treated Big Blue transgenic mice. Toxicol Sci 2004, 82(1):124-128. 10.1093/toxsci/kfh234, 15282403.
14. Shibuya T, Morimoto K. A review of the genotoxicity of 1-ethyl-1-nitrosourea. Mutat Res 1993, 297(1):3-38.
15. Kyriazis AP, Vesselinovitch SD. Transplantability and biological behavior of mouse liver tumors induced by ethylnitrosourea. Cancer Res 1973, 33(2):332-338.
16. Den Engelse L, De Graaf A, De Brij RJ, Menkveld GJ. O2- and O4-ethylthymine and the ethylphosphotriester dTp(Et)dT are highly persistent DNA modifications in slowly dividing tissues of the ethylnitrosourea-treated rat. Carcinogenesis 1987, 8(6):751-757. 10.1093/carcin/8.6.751, 3608071.
17. Watanabe T, Tanaka G, Hamada S, Namiki C, Suzuki T, Nakajima M, Furihata C. Dose-dependent alterations in gene expression in mouse liver induced by diethylnitrosamine and ethylnitrosourea and determined by quantitative real-time PCR. Mutat Res 2009, 673(1):9-20.
18. Vesselinovitch SD, Rao KV, Mihailovich N, Rice JM, Lombard LS. Development of broad spectrum of tumors by ethylnitrosourea in mice and the modifying role of age, sex, and strain. Cancer Res 1974, 34(10):2530-2538.
19. Chen K, Rajewsky N. Deep conservation of microRNA-target relationships and 3'UTR motifs in vertebrates, flies, and nematodes. Cold Spring Harb Symp Quant Biol 2006, 71:149-156. 10.1101/sqb.2006.71.039, 17381291.
20. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, et al. Combinatorial microRNA target predictions. Nat Genet 2005, 37(5):495-500. 10.1038/ng1536, 15806104.
21. Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 2009, 136(4):586-591. 10.1016/j.cell.2009.02.005, 19239879.
22. Pogribny IP, Tryndyak VP, Boyko A, Rodriguez-Juarez R, Beland FA, Kovalchuk O. Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure. Mutat Res 2007, 619(1-2):30-37.
23. Chen PY, Meister G. microRNA-guided posttranscriptional gene regulation. Biol Chem 2005, 386(12):1205-1218. 10.1515/BC.2005.139, 16336116.
24. Kai ZS, Pasquinelli AE. MicroRNA assassins: factors that regulate the disappearance of miRNAs. Nat Struct Mol Biol 2010, 17(1):5-10. 10.1038/nsmb.1762, 20051982.
25. Goth R, Rajewsky MF. Ethylation of nucleic acids by ethylnitrosourea-1- 14 C in the fetal and adult rat. Cancer Res 1972, 32(7):1501-1505.
26. Jansen JG, de Groot AJ, van Teijlingen CM, Lohman PH, Mohn GR, Vrieling H, van Zeeland AA. Formation and persistence of DNA adducts in pouch skin fibroblasts and liver tissue of rats exposed in vivo to the monofunctional alkylating agents N-methyl-N-nitrosourea or N-ethyl-N-nitrosourea. Mutat Res 1994, 307(1):95-105.
27. Morris SM, McGarrity LJ, Domon OE, Chen JJ, Hinson WG, Bucci TJ, Warbritton AR, Casciano DA. The role of programmed cell death in the toxicity of the mutagens, ethyl methanesulfonate and N-ethyl-N'-nitrosourea, in AHH-1 human lymphoblastoid cells. Mutat Res 1994, 306(1):19-34.
28. Pegg AE, Wiest L, Foote RS, Mitra S, Perry W. Purification and properties of O6-methylguanine-DNA transmethylase from rat liver. J Biol Chem 1983, 258(4):2327-2333.
29. Ibeanu G, Hartenstein B, Dunn WC, Chang LY, Hofmann E, Coquerelle T, Mitra S, Kaina B. Overexpression of human DNA repair protein N-methylpurine-DNA glycosylase results in the increased removal of N-methylpurines in DNA without a concomitant increase in resistance to alkylating agents in Chinese hamster ovary cells. Carcinogenesis 1992, 13(11):1989-1995. 10.1093/carcin/13.11.1989, 1423866.
30. Klein JC, Bleeker MJ, Roelen HC, Rafferty JA, Margison GP, Brugghe HF, van den Elst H, van der Marel GA, van Boom JH, Kriek E, et al. Role of nucleotide excision repair in processing of O4-alkylthymines in human cells. J Biol Chem 1994, 269(41):25521-25528.
31. Ying TS, Sarma DS, Farber E. Role of acute hepatic necrosis in the induction of early steps in liver carcinogenesis by diethylnitrosamine. Cancer Res 1981, 41(6):2096-2102.
32. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007, 26(5):731-743. 10.1016/j.molcel.2007.05.017, 17540598.
33. Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007, 21(9):1025-1030. 10.1101/gad.1540407, 1855228, 17437991.
34. Liu X, Jiang L, Wang A, Yu J, Shi F, Zhou X. MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett 2009, 286(2):217-222. 10.1016/j.canlet.2009.05.030, 19540661.
35. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447(7148):1130-1134. 10.1038/nature05939, 17554337.
36. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008, 36(Database issue):D154-158. 2238936, 17991681.
37. Stojic L, Brun R, Jiricny J. Mismatch repair and DNA damage signalling. DNA Repair (Amst) 2004, 3(8-9):1091-1101. 10.1016/j.dnarep.2004.06.006, 15279797.
38. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007, 26(5):745-752. 10.1016/j.molcel.2007.05.010, 1939978, 17540599.
39. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 2007, 67(18):8433-8438. 10.1158/0008-5472.CAN-07-1585, 17823410.
40. Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K. Salmonella mutagenicity tests: V. Results from the testing of 311 chemicals. Environ Mol Mutagen 1992, 19(Suppl 21):2-141. 10.1002/em.2850190603, 1541260.
41. Hamatani T, Carter MG, Sharov AA, Ko MS. Dynamics of global gene expression changes during mouse preimplantation development. Dev Cell 2004, 6(1):117-131. 10.1016/S1534-5807(03)00373-3, 14723852.
42. Tong W, Harris S, Cao X, Fang H, Shi L, Sun H, Fuscoe J, Harris A, Hong H, Xie Q, et al. Development of public toxicogenomics software for microarray data management and analysis. Mutat Res 2004, 549(1-2):241-253.
43. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini M, et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008, 13(3):272-286. 10.1016/j.ccr.2008.02.013, 18328430.
44. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM, Farace MG. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 2005, 334(4):1351-1358. 10.1016/j.bbrc.2005.07.030, 16039986.
45. Malzkorn B, Wolter M, Liesenberg F, Grzendowski M, Stuhler K, Meyer HE, Reifenberger G. Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas. Brain Pathol 2010, 20(3):539-550. 10.1111/j.1750-3639.2009.00328.x, 19775293.
46. Yeung ML, Yasunaga J, Bennasser Y, Dusetti N, Harris D, Ahmad N, Matsuoka M, Jeang KT. Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res 2008, 68(21):8976-8985. 10.1158/0008-5472.CAN-08-0769, 2596768, 18974142.
47. Tong AW, Fulgham P, Jay C, Chen P, Khalil I, Liu S, Senzer N, Eklund AC, Han J, Nemunaitis J. MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther 2009, 16(3):206-216.
48. Ovcharenko D, Kelnar K, Johnson C, Leng N, Brown D. Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res 2007, 67(22):10782-10788. 10.1158/0008-5472.CAN-07-1484, 18006822.
49. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, Rajewsky N, Bender TP, Rajewsky K. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007, 131(1):146-159. 10.1016/j.cell.2007.07.021, 17923094.
50. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res 2008, 14(9):2588-2592. 10.1158/1078-0432.CCR-07-0666, 18451220.
51. Sredni ST, Bonaldo MD, Costa FF, Huang CC, Hamm CA, Rajaram V, Tomita T, Goldman S, Bischof JM, Soares MB. Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets. Childs Nerv Syst 2010, 26(3):279-83. 10.1007/s00381-009-1028-y, 20012062.
52. Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis. Genes Chromosomes Cancer 2009, 48(7):615-623. 10.1002/gcc.20669, 19396864.
53. Petillo D, Kort EJ, Anema J, Furge KA, Yang XJ, Teh BT. MicroRNA profiling of human kidney cancer subtypes. Int J Oncol 2009, 35(1):109-114. 10.3892/ijo_00000318, 19513557.
54. Zhang H, Luo XQ, Zhang P, Huang LB, Zheng YS, Wu J, Zhou H, Qu LH, Xu L, Chen YQ. MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS One 2009, 4(11):e7826. 10.1371/journal.pone.0007826, 2773830, 19915715.
55. Li Z, Lu J, Xu P, Xie X, Chen L, Xu T. Mapping the interacting domains of STIM1 and Orai1 in Ca2 + release-activated Ca2 + channel activation. J Biol Chem 2007, 282(40):29448-29456. 10.1074/jbc.M703573200, 17702753.
56. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, Benes V, Blake J, Pfister S, Eckstein V, et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 2008, 3(5):e2213. 10.1371/journal.pone.0002213, 2374903, 18493317.
57. McDaneld TG, Smith TP, Doumit ME, Miles JR, Coutinho LL, Sonstegard TS, Matukumalli LK, Nonneman DJ, Wiedmann RT. MicroRNA transcriptome profiles during swine skeletal muscle development. BMC Genomics 2009, 10:77. 10.1186/1471-2164-10-77, 2646747, 19208255.
58. Zhu H, Wu H, Liu X, Evans BR, Medina DJ, Liu CG, Yang JM. Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 2008, 76(5):582-588. 10.1016/j.bcp.2008.06.007, 2628586, 18619946.
59. Tchatchou S, Jung A, Hemminki K, Sutter C, Wappenschmidt B, Bugert P, Weber BH, Niederacher D, Arnold N, Varon-Mateeva R, et al. A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. Carcinogenesis 2009, 30(1):59-64. 10.1093/carcin/bgn253, 19028706.
60. Bimpaki EI, Iliopoulos D, Moraitis A, Stratakis CA. MicroRNA signature in massive macronodular adrenocortical disease and implications for adrenocortical tumorigenesis. Clin Endocrinol (Oxf) 2010, 72(6):744-51. 10.1111/j.1365-2265.2009.03725.x, 19849700.
61. Vinuesa CG, Rigby RJ, Yu D. Logic and extent of miRNA-mediated control of autoimmune gene expression. Int Rev Immunol 2009, 28(3-4):112-138. 10.1080/08830180902934909, 19811318.
62. Shan H, Zhang Y, Lu Y, Pan Z, Cai B, Wang N, Li X, Feng T, Hong Y, Yang B. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res 2009, 83(3):465-472. 10.1093/cvr/cvp130, 19398468.
63. Wu H, Mo YY. Targeting miR-205 in breast cancer. Expert Opin Ther Targets 2009, 13(12):1439-1448. 10.1517/14728220903338777, 19839716.
64. Ju X, Li D, Shi Q, Hou H, Sun N, Shen B. Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia. Pediatr Hematol Oncol 2009, 26(1):1-10. 10.1080/08880010802378338, 19206004.